Sechenov School
Home › Microbiology › DNA Oncogenic Viruses: Mechanism of Transformation

DNA-Containing Oncogenic Viruses

For medical students2 min readUpdated 2026-10-10

DNA-containing oncogenic viruses can cause malignant transformation of infected tissues. Instead of typical host cell destruction, they trigger irreversible cellular transformation by blocking natural defense mechanisms against tumor growth.

Cell TypeOncogenesis predominantly occurs in non-permissive cells
GeneticsThe key step of transformation is the expression of early viral genes
TargetsViruses inactivate products of anti-oncogenes (p53 and Rb suppressor proteins)

Cellular Interaction and T-Antigens

Normally, viruses penetrate a cell, replicate within it, and cause its death (lysis). However, oncogenesis follows an entirely different scenario. This process typically takes place in so-called non-permissive cells. In such structures, the virus cannot fully replicate its genome and produce new mature virions for various reasons.

Since lysis does not occur, the cell survives. Instead, its malignant transformation begins. The key stage of this pathological process is the expression of early viral genes. The protein products synthesized based on these genes are named T-antigens (from the Latin term tumor). In most cases, T-antigens localize directly in the cell nucleus, though in rarer situations they may also integrate into the cell membrane, disrupting normal cellular activity.

Interaction with Cellular Suppressors

In a healthy organism, strict control mechanisms prevent uncontrolled division. Specific cellular tumor suppressor proteins, which are products of anti-oncogenes, are responsible for this control. The primary mechanism of viral oncogenesis by DNA viruses lies in the targeted and inactivation of these critical protective proteins.

The main targets for viral T-antigens are two proteins:

The p53 Cascade and Viral Blockade

To fully understand the danger of oncogenic viruses, one must examine the normal function of the p53 phosphoprotein. In an uninfected cell, it operates via the following algorithm:

  1. Upon any physical or chemical DNA damage, p53 synthesis increases instantaneously.
  2. Accumulated p53 acts as a transcription factor activating another important protein — WAFI.
  3. The WAFI protein binds cellular cyclins and completely inactivates them.
  4. As a result, the cell cycle is forcibly halted, giving enzymes time to repair damaged DNA.
  5. If repair is successful, p53 levels drop rapidly, and normal cell division resumes.

What happens during viral oncogenesis? Viral proteins intervene in this process and tightly block the p53 phosphoprotein. Consequently, the protective cascade is not triggered: the cell cycle does not halt, and repair is not performed. The virus allows active division of cells with already damaged genomes, inevitably leading to tumor formation.

Mnemonic

Imagine a cell is a car. The p53 and Rb proteins are reliable brakes. Viral T-antigens (Tumor) cut the brake lines (inactivating suppressors). The car can no longer stop for 'repairs' (DNA repair) and crashes at full speed into the abyss of uncontrolled division.

Frequently asked questions

Which families of DNA-containing viruses are classified as oncogenic?

The Papillomaviridae family possesses oncogenic potential: papillomaviruses infect the skin and mucous membranes, induce epithelial proliferation, and can cause dysplasia and cancer. The classification of other listed families as oncogenic is not covered in the provided materials.

Which specific oncoproteins of human papillomavirus (HPV) inactivate p53 and Rb?

Proteins p53 and Rb are inactivated by early functional proteins of the human papillomavirus.

These oncoproteins include:

  • E6 protein — an early gene product, acting as a marker of oncogenicity.
  • E7 protein — an early gene product, also acting as a marker of oncogenicity.

These viral proteins inactivate tumor suppressor genes, leading to loss of cell cycle control and uncontrolled cellular proliferation.

How does the interaction of an oncogenic virus differ between permissive and non-permissive cells?

In a permissive cell, a productive infection develops: a full replication cycle occurs and infectious progeny are formed. In a non-permissive cell, the virus cannot fully replicate or produce new virions; instead of lysis, cell transformation associated with oncogenesis takes place.

Why does malignant transformation occur specifically in non-permissive cells?

In non-permissive cells, the virus is physically unable to complete the replication cycle and assemble new virions. Therefore, classical lysis (destruction) of the cell does not occur, and early viral genes have time to trigger the transformation of the surviving cell.

What are T-antigens and where are they located?

T-antigens are protein products of early viral gene expression responsible for tumor transformation (derived from tumor). They are predominantly located inside the cell nucleus, but are sometimes found on the cell membrane.

What is the role of the WAFI protein in protecting the cell from oncogenesis?

The WAFI protein, whose synthesis is activated by the p53 phosphoprotein upon DNA damage, binds and inactivates cyclins. This leads to a temporary arrest of the cell cycle, allowing time for the repair of damaged genetic material.

Go deeper

More topics in Microbiology

ProteusRelapsing FeversChlamydophila pneumoniae: Pathogen of Respiratory ChlamydiosisPathogenesis and Clinical Features of InfluenzaRespiratory Syncytial VirusHepatitis A VirusClinical Presentation of HIV InfectionJapanese Encephalitis VirusTrichophytosis: Types, Pathogens and MorphologyParacoccidioidomycosisPenicilliosis (Penicillium)TrichomonasMicrobiology →